Ellagic acid ameliorates cisplatin-induced acute kidney injury by regulating inflammation and SIRT6/TNF-α signaling

Pabla, 2008, Cisplatin nephrotoxicity: mechanisms and renoprotective strategies, Kidney Int, 73, 994, 10.1038/sj.ki.5002786 Siddik, 2003, Cisplatin: mode of cytotoxic action and molecular basis of resistance, Oncogene, 22, 7265, 10.1038/sj.onc.1206933 Chang, 2020, SIRT6, a mammalian deacylase with multitasking abilities, Physiol Rev, 100, 145, 10.1152/physrev.00030.2018 Kawahara, 2009, SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span, Cell, 136, 62, 10.1016/j.cell.2008.10.052 Michishita, 2009, Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6, Cell Cycle, 8, 2664, 10.4161/cc.8.16.9367 Tasselli, 2016, SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence, Nat Struct Mol Biol, 23, 434, 10.1038/nsmb.3202 Tasselli, 2017, SIRT6: novel mechanisms and links to aging and disease, Trends Endocrinol Metab, 28, 168, 10.1016/j.tem.2016.10.002 Liu, 2021, Emerging roles of SIRT6 in human diseases and its modulators, Med Res Rev, 41, 1089, 10.1002/med.21753 Bhardwaj, 2016, SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions, Proc Natl Acad Sci USA, 113, E538, 10.1073/pnas.1520045113 Dominy, 2012, The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis, Mol Cell, 48, 900, 10.1016/j.molcel.2012.09.030 Liszt, 2005, Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase, J Biol Chem, 280, 21313, 10.1074/jbc.M413296200 Feldman, 2013, Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins, J Biol Chem, 288, 31350, 10.1074/jbc.C113.511261 Li, 2018, Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1/2 signaling, Kidney Int, 93, 881, 10.1016/j.kint.2017.10.021 Ceci, 2018, Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid, Nutrients, 10, 1756, 10.3390/nu10111756 Alfei, 2019, Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review, Eur J Med Chem, 183, 10.1016/j.ejmech.2019.111724 Ahmed, 2016, Insights into effects of ellagic acid on the nervous system: a mini review, Curr Pharm Des, 22, 1350, 10.2174/1381612822666160125114503 Heber, 2008, Multitargeted therapy of cancer by ellagitannins, Cancer Lett, 269, 262, 10.1016/j.canlet.2008.03.043 Vanella, 2013, Effects of ellagic acid on angiogenic factors in prostate cancer cells, Cancers, 5, 726, 10.3390/cancers5020726 Wu, 2019, A new flavone glucoside together with known ellagitannins and flavones with anti-diabetic and anti-obesity activities from the flowers of pomegranate (Punica granatum), Nat Prod Res, 33, 252, 10.1080/14786419.2018.1446009 BenSaad, 2017, Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum, BMC Complement Altern Med, 17, 47, 10.1186/s12906-017-1555-0 Khateeb, 2010, Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway, Atherosclerosis, 208, 119, 10.1016/j.atherosclerosis.2009.08.051 Rahnasto-Rilla, 2020, Effects of galloflavin and ellagic acid on sirtuin 6 and its anti-tumorigenic activities, Biomed Pharmacother, 131, 10.1016/j.biopha.2020.110701 Miller, 2010, Mechanisms of cisplatin nephrotoxicity, Toxins, 2, 2490, 10.3390/toxins2112490 He, 2017, SIRT6 inhibits TNF-α-induced inflammation of vascular adventitial fibroblasts through ROS and Akt signaling pathway, Exp Cell Res, 357, 88, 10.1016/j.yexcr.2017.05.001 Zhang, 2021, Cisplatin chemotherapy and renal function, Adv Cancer Res, 152, 305, 10.1016/bs.acr.2021.03.008 Gómez-Sierra, 2018, Role of food-derived antioxidants against cisplatin induced-nephrotoxicity, Food Chem Toxicol, 120, 230, 10.1016/j.fct.2018.07.018 Crona, 2017, A systematic review of strategies to prevent Cisplatin-induced nephrotoxicity, Oncologist., 22, 609, 10.1634/theoncologist.2016-0319 Hakiminia, 2019, has vitamin E any shreds of evidence in cisplatin-induced toxicity, J Biochem Mol Toxicol, 33, 10.1002/jbt.22349 Liu, 2017, Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling, Nat Commun, 8, 413, 10.1038/s41467-017-00498-4 Falsaperla, 2005, Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate, Eur Urol, 47, 449, 10.1016/j.eururo.2004.12.001 Nuñez-Sánchez, 2017, Gene expression changes in colon tissues from colorectal cancer patients following the intake of an ellagitannin-containing pomegranate extract: a randomized clinical trial, J Nutr Biochem, 42, 126, 10.1016/j.jnutbio.2017.01.014 Paller, 2013, A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer, Prostate Cancer Prostatic Dis, 16, 50, 10.1038/pcan.2012.20 Pantuck, 2006, Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer, Clin Cancer Res, 12, 4018, 10.1158/1078-0432.CCR-05-2290